Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121342656A reveals copper-catalyzed BCN-OSu synthesis improving yield and purity. Enables cost reduction and reliable supply chain for bio-orthogonal reagents.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Novel chiral auxiliary method for Tapentadol intermediates. High purity, scalable process reducing costs and lead time for pharmaceutical manufacturing supply chains.
Patent CN106366022B reveals high-yield AZD9291 intermediate synthesis. Offers cost reduction in API manufacturing and supply chain reliability for global buyers.
Analysis of patent CN103819418A reveals a safer, high-purity synthesis route for Carfentrazone-ethyl intermediates, offering significant cost reduction and supply chain stability for agrochemical manufacturers.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel hydrogenation process reduces noble metal usage and improves purity for sitagliptin manufacturing, offering significant cost and supply chain advantages.
Patent CN103408573A reveals a novel NHC-catalyzed borylation method for high-purity boronic acid derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN118666829A reveals high-yield cyclization for cyantraniliprole intermediates, offering reduced waste and scalable manufacturing for global supply chains.
Novel boron-catalyzed condensation and low-temp cyclization for high-purity remimazolam intermediates, offering scalable supply chain solutions.
Novel method for directional acyl migration using sulfonic acid. Enhances purity and reduces costs for API intermediate manufacturing with mild conditions.
Patent CN109678718B reveals a green one-step method for phenylpropionate derivatives. Achieve high purity and cost reduction in pharma intermediate manufacturing.
Patent CN101628889A reveals a high-yield toluene-based route for Donepezil key intermediates, offering significant cost and purity advantages for API manufacturers.
Patent CN100383144C reveals a safe, high-yield route for olanzapine intermediates using diester dicarbonates, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103130862B reveals a safer synthesis route for ulipristal acetate intermediates, offering significant supply chain stability and cost reduction benefits for pharmaceutical manufacturing.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.